Bridget K. Wagner

10.8k total citations · 3 hit papers
83 papers, 5.7k citations indexed

About

Bridget K. Wagner is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Bridget K. Wagner has authored 83 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 29 papers in Surgery and 18 papers in Genetics. Recurrent topics in Bridget K. Wagner's work include Pancreatic function and diabetes (28 papers), Computational Drug Discovery Methods (13 papers) and Genetics and Neurodevelopmental Disorders (9 papers). Bridget K. Wagner is often cited by papers focused on Pancreatic function and diabetes (28 papers), Computational Drug Discovery Methods (13 papers) and Genetics and Neurodevelopmental Disorders (9 papers). Bridget K. Wagner collaborates with scholars based in United States, Austria and Denmark. Bridget K. Wagner's co-authors include Paul A. Clemons, Vlado Dančík, Stuart L. Schreiber, Monica Schenone, Amedeo Vetere, Alykhan F. Shamji, Douglas A. Melton, Maayan Baron, Allon M. Klein and Samuel L. Wolock and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Bridget K. Wagner

82 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Single-Cell Transcriptomic Map of the Human and Mouse Pancreas Reveals Inter- and Intra-cell Population Structure

2016 913 citations Amedeo Vetere, Bridget K. Wagner et al. profile →
Target identification and mechanism of action in chemical biology and drug discovery

2013 745 citations Vlado Dančík, Bridget K. Wagner et al. profile →
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis

2019 663 citations Maria Kost‐Alimova, Vlado Dančík et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bridget K. Wagner United States	34	3.6k	990	747	746	628	83	5.7k
Maurizio Pellecchia United States	56	7.7k 2.1×	439 0.4×	870 1.2×	1.3k 1.7×	1.1k 1.8×	205	11.1k
Matthieu Schapira Canada	46	8.2k 2.3×	485 0.5×	527 0.7×	647 0.9×	559 0.9×	114	10.4k
Ajit Jadhav United States	50	5.1k 1.4×	279 0.3×	543 0.7×	498 0.7×	929 1.5×	150	8.1k
Michael Höcker Germany	29	2.6k 0.7×	804 0.8×	438 0.6×	233 0.3×	238 0.4×	61	4.3k
Robert T. Nolte United States	27	4.3k 1.2×	362 0.4×	388 0.5×	1.4k 1.9×	623 1.0×	33	5.8k
Carlotta Granchi Italy	32	2.3k 0.7×	278 0.3×	1.4k 1.8×	365 0.5×	432 0.7×	109	4.1k
Peter J. Tummino United States	34	2.7k 0.8×	393 0.4×	309 0.4×	187 0.3×	529 0.8×	76	4.8k
Yong Xu China	39	2.9k 0.8×	168 0.2×	540 0.7×	370 0.5×	716 1.1×	171	5.1k
Chi‐Ying F. Huang Taiwan	46	6.1k 1.7×	335 0.3×	1.7k 2.3×	385 0.5×	208 0.3×	233	8.5k
Christopher L. Morton United States	45	3.2k 0.9×	197 0.2×	663 0.9×	475 0.6×	389 0.6×	128	5.6k

Countries citing papers authored by Bridget K. Wagner

Since Specialization

Citations

This map shows the geographic impact of Bridget K. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget K. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget K. Wagner more than expected).

Fields of papers citing papers by Bridget K. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bridget K. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget K. Wagner. The network helps show where Bridget K. Wagner may publish in the future.

Co-authorship network of co-authors of Bridget K. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Bridget K. Wagner. A scholar is included among the top collaborators of Bridget K. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bridget K. Wagner. Bridget K. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Devkota, Ranjan, et al.. (2024). KD025 Is a Casein Kinase 2 Inhibitor That Protects Against Glucolipotoxicity in β-Cells. Diabetes. 73(4). 585–591. 2 indexed citations

Kahraman, Sevim, Kimitaka Shibue, Dario F. De Jesus, et al.. (2023). Fluorescein-based sensors to purify human α-cells for functional and transcriptomic analyses. eLife. 12. 1 indexed citations

Moshkov, Nikita, Tim Becker, Kevin Yang, et al.. (2023). Predicting compound activity from phenotypic profiles and chemical structures. Nature Communications. 14(1). 1967–1967. 40 indexed citations

Basile, Giorgio, Amedeo Vetere, Jiang Hu, et al.. (2023). Excess pancreatic elastase alters acinar-β cell communication by impairing the mechano-signaling and the PAR2 pathways. Cell Metabolism. 35(7). 1242–1260.e9. 9 indexed citations

Wagner, Bridget K.. (2022). Small-molecule discovery in the pancreatic beta cell. Current Opinion in Chemical Biology. 68. 102150–102150. 6 indexed citations

Kost‐Alimova, Maria, Kumiko Ayukawa, Carol Khodier, et al.. (2022). Phenotypic Screening for Small Molecules that Protect β-Cells from Glucolipotoxicity. ACS Chemical Biology. 17(5). 1131–1142. 3 indexed citations

Khanna, Dinesh, Celia J. F. Lin, Daniel E. Furst, et al.. (2021). Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 205(6). 674–684. 72 indexed citations

Dahlin, Jayme L., Douglas S. Auld, Ina Rothenaigner, et al.. (2021). Nuisance compounds in cellular assays. Cell chemical biology. 28(3). 356–370. 33 indexed citations

Lee, Miseon, Basudeb Maji, Debasish Manna, et al.. (2020). Native Zinc Catalyzes Selective and Traceless Release of Small Molecules in β-Cells. Journal of the American Chemical Society. 142(14). 6477–6482. 22 indexed citations

10.

Simon, Christian, Marie Balslev Backe, Mattias Salling Dahllöf, et al.. (2020). Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells. International Journal of Molecular Sciences. 21(21). 8016–8016. 6 indexed citations

11.

Yang, Kisuk, Miseon Lee, Peter A. Jones, et al.. (2020). A 3D culture platform enables development of zinc-binding prodrugs for targeted proliferation of β cells. Science Advances. 6(47). 26 indexed citations

12.

Dirice, Ercument, Deepika Walpita, Amedeo Vetere, et al.. (2016). Inhibition of DYRK1A Stimulates Human β-Cell Proliferation. Diabetes. 65(6). 1660–1671. 150 indexed citations

13.

Dahllöf, Mattias Salling, et al.. (2014). HDAC Inhibitor-Mediated Beta-Cell Protection Against Cytokine-Induced Toxicity Is STAT1 Tyr701 Phosphorylation Independent. Journal of Interferon & Cytokine Research. 35(1). 63–70. 11 indexed citations

14.

Yuan, Yuan, Kate Hartland, Žarko Bošković, et al.. (2014). A Small-Molecule Inducer of PDX1 Expression Identified by High-Throughput Screening. Chemistry & Biology. 21(2). 306–306. 1 indexed citations

15.

Fomina‐Yadlin, Dina, Stefan Kubicek, Amedeo Vetere, et al.. (2012). Correction: GW8510 Increases Insulin Expression in Pancreatic Alpha Cells through Activation of p53 Transcriptional Activity. PLoS ONE. 7(3). 1 indexed citations

16.

Vetere, Amedeo & Bridget K. Wagner. (2012). Chemical Methods to Induce Beta-Cell Proliferation. International Journal of Endocrinology. 2012. 1–8. 18 indexed citations

17.

Walpita, Deepika, Thomas P. Hasaka, James Spoonamore, et al.. (2011). A Human Islet Cell Culture System for High-Throughput Screening. SLAS DISCOVERY. 17(4). 509–518. 44 indexed citations

18.

Fomina‐Yadlin, Dina, Stefan Kubicek, Deepika Walpita, et al.. (2010). Small-molecule inducers of insulin expression in pancreatic α-cells. Proceedings of the National Academy of Sciences. 107(34). 15099–15104. 58 indexed citations

19.

Clemons, Paul A., Nicole E. Bodycombe, Joshua Wilson, et al.. (2010). Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles. Proceedings of the National Academy of Sciences. 107(44). 18787–18792. 280 indexed citations

20.

Clemons, Paul A., Nicola Tolliday, & Bridget K. Wagner. (2009). Cell-based assays for high-throughput screening : methods and protocols. Humana Press eBooks. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact